CAS Insights^TM

As antimicrobial resistance becomes a larger problem, new approaches to battling infections are emerging.

See how new innovations like biorefineries, waste repurposing, and materials are reshaping the future of sustainable fertilizers.

Experts from Lawrence Livermore National Lab, Oak Ridge National Lab, The Ohio State University, and CAS discuss major research trends in 2024.

As cancer is projected to increase, finding stronger therapeutics is more urgent. Biomarkers offer a potential solution for better diagnosis and treatment.

CAS and Excelra delved into data surrounding biomarkers and their relationship to cancer to identify key targets for future study.

Discover how AI in the food industry is transforming production, innovation, and sustainability. Learn how AI can help you create smarter and more efficient food solutions.

Immunotherapy is advancing with new approaches like CAR-T cell therapy, antibody-drug conjugates, and even checkpoint inhibitors.

AI is redefining natural product drug discovery by unlocking diverse candidates from plants, microbes, and more.

Antimicrobial-resistant infections are a global public health crisis. New solutions like AI, alternative therapeutics, and innovations in materials offer a way to fight back.

Stay ahead of the latest scientific breakthroughs that are accelerating the landscape of innovation and will transform global science in 2024

Learn how digital transformation is reducing waste and creating new revenue streams for companies as they repurpose waste byproducts.

Immuno-oncology has the potential to treat cancer without sacrificing the patient's wellbeing.

The pharma industry is tackling major drug discovery challenges in several new ways. Have they been successful?

In this article, we speak with Nicole Stobart, Jeff Wilson, and Mark Schmidt, about how CAS is using authority constructs to index biological molecules.

Pharmaceutical manufacturers are investigating ways to cultivate insights from dark formulations data, turning once-hidden knowledge into drug discoveries.

With the push towards increased sustainability, here are four ways coatings manufacturers are making use of renewable feedstock for their own products.

As the drug repurposing market grows, pharmaceutical manufacturers are investigating ways to cultivate insights from dark formulations data, turning once hidden insights into drug repurposing innovations.

Ozempic, Wegovy, and Mounjaro are part of a new class of semaglutides (GLP-1 receptor agonists) that help treat obesity and diabetes by regulating blood sugar and appetite.

Learn how photocatalysis can produce clean hydrogen from water and solar energy and why it is crucial for decarbonization.

CAS and Totus Medicines discuss how targeted covalent inhibitors are revolutionizing cancer treatments.

Single-walled carbon nanotubes have great potential in several industries from renewable energy to drug delivery.

Iddo Friedberg, an expert in protein function prediction, shares how current prediction models are performing and what current bottlenecks remain.

Covalent inhibitors were once avoided due to negative side effects, but new drugs have changed the landscape.

Drugs created with covalent inhibitors are becoming more popular than other types, owing to their unique mechanism of action.

More than 100 antibody-drug conjugates are in clinical trials. These therapeutics combine the targeting abilities of antibodies with the power of chemotherapy to change cancer treatment.